Table 4.
Multiple linear regression analysis of T cell subsets and cytokines adjusted with BMI.
| Group | β | SE | Adjust β | t | P | |
|---|---|---|---|---|---|---|
| LgIL-6 | DM | 0 (ref.) | ||||
| NG | -0.45 | 0.19 | -0.39 | -2.37 | 0.02 | |
| IGR | -0.28 | 0.21 | -0.22 | -1.35 | 0.18 | |
| LgINFγ | DM | 0 (ref.) | ||||
| NG | -0.09 | 0.06 | -0.27 | -1.64 | 0.11 | |
| IGR | -0.12 | 0.06 | -0.34 | -2.10 | 0.04 | |
| LgTNFα | DM | 0 (ref.) | ||||
| NG | -0.00 | 0.09 | -0.00 | -0.01 | 0.99 | |
| IGR | -0.14 | 0.10 | -0.23 | -1.37 | 0.18 | |
| LgIL-4 | DM | 0 (ref.) | ||||
| NG | -0.03 | 0.06 | -0.08 | -0.49 | 0.63 | |
| IGR | -0.09 | 0.07 | -0.22 | -1.32 | 0.19 | |
| LgIL-2 | DM | 0 (ref.) | ||||
| NG | -0.03 | 0.04 | -0.12 | -0.68 | 0.50 | |
| IGR | -0.07 | 0.04 | -0.28 | -1.71 | 0.09 | |
| LgIL-10 | DM | 0 (ref.) | ||||
| NG | -0.14 | 0.04 | -0.48 | -3.10 | 0.00 | |
| IGR | -0.13 | 0.05 | -0.40 | -2.68 | 0.01 | |
| CD4 | DM | 0 (ref.) | ||||
| NG | -7.31 | 3.03 | -0.41 | -2.42 | 0.02 | |
| IGR | -7.28 | 3.32 | -0.36 | -2.19 | 0.03 | |
| CD8 | DM | 0 (ref.) | ||||
| NG | 5.29 | 3.02 | 0.30 | 1.75 | 0.09 | |
| IGR | 3.76 | 3.31 | 0.19 | 1.14 | 0.26 | |
| LgCD4/CD8 | DM | 0 (ref.) | ||||
| NG | -0.18 | 0.07 | -0.41 | -2.45 | 0.02 | |
| IGR | -0.13 | 0.08 | -0.27 | -1.67 | 0.10 |
NDM: nondiabetes mellitus; IFG: impaired fasting glucose; DM: diabetes mellitus.